Polycystic ovary syndrome.
Polycystic ovary syndrome.
复制标题
DOI:
10.1201/9780203910948
复制
发表时间:
1992-02
期刊:
影响因子:
--
通讯作者:
R. Azziz;E. Carmina;Zi-jiang Chen;A. Dunaif;J. Laven;R. Legro;Daria Lizneva;Barbara Natterson-Horowtiz-Barbara-Natte
中科院分区:
文献类型:
--
作者:
R. Azziz;E. Carmina;Zi-jiang Chen;A. Dunaif;J. Laven;R. Legro;Daria Lizneva;Barbara Natterson-Horowtiz-Barbara-Natte
Polycystic ovary syndrome (PCOS) is a common gynecologic endocrinopathy. The pathogenesis of PCOS is associated with both heredity and environment. PCOS has adverse impacts on female endocrine, reproduction, and metabolism. PCOS can impact women’s reproductive health, leading to anovulatory infertility and higher rate of early pregnancy loss. PCOS has additional metabolic derangements, such as insulin resistance, impaired glucose tolerance, and dyslipidemia. The risks of diabetes, cardiovascular disease, hypertension, metabolic syndrome, and endometrial cancer among PCOS patients are significantly increased as well.